Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges

Area of Science:

• Oncology
• Molecular Biology

Background:

• Gastric cancer is a leading cause of cancer mortality globally.
• Multidrug resistance (MDR) to chemotherapy is a primary reason for treatment failure in gastric cancer.
• Classical ATP-binding cassette transporters like P-glycoprotein (P-gp) and MDR-associated protein (MRP)1 are known mediators of MDR.

Purpose of the Study:

• To investigate novel molecular mechanisms underlying gastric cancer multidrug resistance (MDR).
• To identify potential new therapeutic targets for overcoming MDR in gastric cancer.

Main Methods:

• Review of recent research on gastric cancer MDR mechanisms.
• Analysis of studies identifying molecules beyond P-gp and MRP1 involved in drug resistance.
• Exploration of functional families of newly identified MDR-mediating molecules.

Main Results:

• Several molecules, in addition to P-gp and MRP1, have been identified as potential mediators of gastric cancer MDR.
• Absence of P-gp and MRP1 expression in some cases suggests alternative MDR pathways.
• These newly identified molecules belong to diverse functional families and may act synergistically.

Conclusions:

• Gastric cancer MDR involves a complex interplay of multiple molecular mechanisms.
• New therapeutic strategies targeting these novel molecules could overcome chemotherapy resistance.
• Further research into these MDR mediators is crucial for improving gastric cancer treatment outcomes.